MAPT and Alzheimer disease: Their genetic background makes them highly suited for exploring core aspects of AD pathology, such as amyloid-beta (Aβ) aggregation, tau hyperphosphorylation, neuroinflammation, synaptic dysfunction, and cognitive decline.